SWTX
$60.95
Springworks Therapeutics
$1.05
1.75%
SWTX
Earnings Whisper ®
N/A
3rd Quarter September 2020
Consensus:  ($0.49)
Revenue:  $0.00 Mil
Tuesday
Nov 10
Before the open
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when SWTX reports earnings?
Beat
Meet
Miss

Where is SWTX's stock price going from here?
Up
Flat
Down
Stock chart of SWTX
Analysts
Summary of analysts' recommendations for SWTX
Score
Grade
Pivots
Resistance
$66.20
$64.62
$62.79

$61.21

Support
$59.37
$57.79
$55.96
Tweet
Growth
Description
SpringWorks Therapeutics Inc. is a clinical-stage biopharmaceutical company. It is focused on developing life-changing medicines for patients with severe rare diseases and cancer. The company's product pipeline consists of Nirogacestat and Mirdametinib which are in clinical stage. SpringWorks Therapeutics Inc. is based in Stamford, United States.